ADVANCED LEIOMYOSARCOMA
Clinical trials for ADVANCED LEIOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED LEIOMYOSARCOMA trials appear
Sign up with your email to follow new studies for ADVANCED LEIOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo tackles rare sarcoma in early trial
Disease control OngoingThis study tests a combination of two drugs, lurbinectedin and doxorubicin, in people with advanced soft-tissue sarcoma or leiomyosarcoma that cannot be cured with standard treatments. The first part finds a safe dose, and the second part compares the combination to lurbinectedin…
Matched conditions: ADVANCED LEIOMYOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
Tumor avatars could personalize sarcoma therapy
Disease control ENROLLING_BY_INVITATIONThis study aims to see if growing a patient's tumor cells in the lab (called organoids) can help doctors choose the most effective first-line chemotherapy for advanced leiomyosarcoma, a rare cancer of smooth muscle. About 50 adults aged 18-75 who have not yet received systemic tr…
Matched conditions: ADVANCED LEIOMYOSARCOMA
Phase: NA • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC